| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| CMP | Cardio-Myo-Pathy |
| CMP | cardiomyopathy; cartilage matrix protein; chondromalacia patellae; collagen binding protein; competi... |
| OAS | old age security; oral allergy syndrome; osmotically active substance |
| OCP | octacalcium phosphate; ocular cicatricial pemphigoid; oral case presentation; oral contraceptive pil... |
| OAS | Oral Allergy Syndrome |
|---|---|
| CMA | Cow's milk allergy |
| F.A. | Food Allergy |
| LAA | Laboratory Animal Allergy |
| NIAID | National Institute of Allergy and Infectious Disease |
| CMP | Symbol for cytidine 5'-monophosphate (secondarily, for any cytidine monophosphate). (05 Mar 2000) |
|---|---|
| CMP-acetylneuraminate-alpha-N-acetylneuramide alpha-2,8-sialyltransferase | <enzyme> Forms ganglioside gd3 Registry number: EC 2.4.99.8 Synonym: cmp-n-acetylneuraminate-gm3 sialyltransferase, gm3-sialosyltransferase, gd3 synthase, gd3-synthase, cmp-n-acetylneuraminate-(n-acetylneuraminyl)-d-galactosyl-d-glucosylceramide sialyltransferase, sialyltransferase II, st II, g(m3) alpha-2,8-sialyltransferase, st8sia I, stii enzyme, stiii enzyme, gt3 synthase (26 Jun 1999) |
| CMP-N-acetylneuraminate-alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase | <enzyme> Enzyme from foetal calf liver; forms branched tetrasaccharide, neuac-alpha2-3gal-beta1-3(neuac-alpha2-6)galnac of fetuin Registry number: EC 2.4.99.3 Synonym: cmp-aag-sialyltransferase, st6galnaci, galnac 2,6-sialyltransferase (26 Jun 1999) |
| CMP-N-acetylneuraminic acid-monosialoganglioside sialyltransferase | <enzyme> Converts ga1 to gm1b, gm1 to gd1a and gd1b to gt1b Registry number: EC 2.4.99.2 Synonym: cmp-n-acetylneuraminic acid-asialo-gm1 sialyltransferase, gm1b synthase, gd1a synthase, gt1b synthase, cmp-neuac - gm1(alpha2-3)sialyltransferase, cmp-n-acetylneuraminate-gm(1) sialyltransferase, sat iv, sat-4 enzyme (26 Jun 1999) |
| CTP-CMP-3-deoxynonulosonate cytidyltransferase | <enzyme> From testis of rainbow trout; responsible for synthesis of cmp-deaminoneuraminic acid from deaminoneuraminic acid and ctp; presence of mg(2+) or mn(2+) essential for activity Registry number: EC 2.7.7.- Synonym: cmp-kdn synthetase (26 Jun 1999) |
| cyclic cmp | <chemical> Cytidine cyclic 3',5'-(hydrogen phosphate). It is formed in mammalian tissue by the enzymatic conversion of cytidine triphosphate and may play a role in the bioregulation of proliferation of normal and malignant cells. Chemical name: Cytidine, cyclic 3',5'-(hydrogen phosphate) (12 Dec 1998) |
| allergy | 1. <immunology> A state of hypersensitivity induced by exposure to a particular antigen (allergen) resulting in harmful immunologic reactions on subsequent exposures, the term is usually used to refer to hypersensitivity to an environmental antigen (atopic allergy or contact dermatitis) or to drug allergy. The original meaning, now obsolete, included all states of altered immunologic reactivity, immunity as well as hypersensitivity. Gell and Coombs used the term allergic reaction to mean any harmful immunologic reaction causing tissue injury. 2. <study> The medical specialty dealing with diagnosis and treatment of allergic disorders. (18 Nov 1997) |
| allergy and immunology | A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder. (12 Dec 1998) |
| allergy desensitization | Stimulation of the immune system with gradually increasing doses of the substances to which a person is allergic, the aim being to modify or stop the allergy war (by reducing the strength of the IgE and its effect on the mast cells). This form of treatment is very effective for allergies to pollen, mites, cats, and especially stinging insects (e.g., bees, hornets, yellowjackets, wasps, velvet ants, fire ants). Allergy immunotherapy usually takes 6 months to a year to become effective and injections ( shots ) are usually required for 3-5 years. (12 Dec 1998) |
| allergy shots | See Allergy desensitization. (12 Dec 1998) |
| allergy skin test | Test done on the skin to identify the allergy substance (allergen) triggering the allergic reaction. A small amount of the suspected allergy substance is placed on the skin. The skin is then gently scratched through the small drop with a special sterile needle. If the skin reddens and, more importantly, swells, then allergy to that substance is probable. (12 Dec 1998) |
| allergy testing | <investigation> A common method of screening a patient for potential allergies. May be given as a patch or a skin test (injection). (27 Sep 1997) |
| atopic allergy | <immunology> An allergic reaction with strong family tendencies. (09 Oct 1997) |
| bacterial allergy | The concept that the atopic kind of type I allergic reactions may be caused by bacterial allergens, the delayed type of skin test, so-called because of its early association with bacterial antigens (e.g., the tuberculin test). (05 Mar 2000) |
| physical allergy | Excessive response to factors in the environment such as heat or cold. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|